Live Breaking News & Updates on Processa Pharmaceuticals Stock Down

Stay updated with breaking news from Processa pharmaceuticals stock down. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Processa Pharmaceuticals (NASDAQ:PCSA) Receives "Buy" Rating from HC Wainwright

HC Wainwright reaffirmed their buy rating on shares of Processa Pharmaceuticals (NASDAQ:PCSA – Free Report) in a report published on Monday, Benzinga reports. HC Wainwright currently has a $8.00 target price on the stock. HC Wainwright also issued estimates for Processa Pharmaceuticals’ Q2 2024 earnings at ($0.98) EPS, Q3 2024 earnings at ($1.02) EPS, FY2024 […] ....

Processa-pharmaceuticals-company-profile , Processa-pharmaceuticals-inc , News-ratings-for-processa-pharmaceuticals-daily , Processa-pharmaceuticals-stock-down , Institutional-investors-weigh-in-on-processa-pharmaceuticals , Processa-pharmaceuticals , Nasdaq , Free-report , Pharmaceuticals-stock-down , Get-free-report , Processa-pharmaceuticals-daily

Processa Pharmaceuticals Stock Scheduled to Reverse Split on Monday, January 22nd (NASDAQ:PCSA)

Processa Pharmaceuticals, Inc. (NASDAQ:PCSA – Free Report) shares are going to reverse split before the market opens on Monday, January 22nd. The 1-20 reverse split was announced on Monday, January 22nd. The number of shares owned by shareholders will be adjusted after the closing bell on Monday, January 22nd. Processa Pharmaceuticals Stock Down 25.3 % […] ....

Processa-pharmaceuticals-stock-down , Dimensional-fund-advisors , Processa-pharmaceuticals-company-profile , Renaissance-technologies , Processa-pharmaceuticals , Raymond-james-financial-services-advisors-inc , Nasdaq , Sigma-securities , Citadel-advisors , Maxim-group , Processa-pharmaceuticals-inc